MDT
95.62
+0.1%↑
VEEV
286.22
-0.26%↓
A
138.32
+1.29%↑
HQY
93.32
+3.04%↑
PHR.US
22.18
-0.63%↓
MDT
95.62
+0.1%↑
VEEV
286.22
-0.26%↓
A
138.32
+1.29%↑
HQY
93.32
+3.04%↑
PHR.US
22.18
-0.63%↓
MDT
95.62
+0.1%↑
VEEV
286.22
-0.26%↓
A
138.32
+1.29%↑
HQY
93.32
+3.04%↑
PHR.US
22.18
-0.63%↓
MDT
95.62
+0.1%↑
VEEV
286.22
-0.26%↓
A
138.32
+1.29%↑
HQY
93.32
+3.04%↑
PHR.US
22.18
-0.63%↓
MDT
95.62
+0.1%↑
VEEV
286.22
-0.26%↓
A
138.32
+1.29%↑
HQY
93.32
+3.04%↑
PHR.US
22.18
-0.63%↓
24h
Atual
Mín
2.69
Máximo
2.82
Recomendações | Comprar |
---|---|
Previsão para 12 meses | +435.06% upside |
Próximos Ganhos | 12 de nov. de 2025 |
---|
O desempenho passado não é um indicador confiável de resultados futuros.
1 de out. de 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Ler
10 de mar. de 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Ler
10 de mar. de 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Ler
10 de mar. de 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Ler
10 de mar. de 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Ler
10 de mar. de 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Ler
10 de mar. de 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Ler
10 de mar. de 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Ler
Variação de preço
By TipRanks
Previsão para 12 meses
Média 14.5 USD 435.06%
Máximo 17 USD
Mínimo 12 USD
Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Fortress Biotech Inc - Dist nos últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Manter
0
Vender
Com base em 2 analistas que deram avaliações de ações para Fortress Biotech Inc - Dist nos últimos 3 meses.
$